Anti epileptics Flashcards
Types of seizures
- Generalised seizure:
• GTCS/ myoclonic seizures/ JME
• absence seizures - Partial seizures
Cause of generalised tonic clonic seizure
- Thalamus
- Spontaneous firing of T-type Ca channel
- Action potential
- In cortex: retrograde propagation of action potential
- Cortical neuron depolarisation
- Na channel opens
- Depolarisation of spinal cord segments
- Spontaneous contraction and relaxation of all muscles
Mechanism of absence seizures
- Thalamus
- Spontaneous firing of T type Ca channels
- Action potential within subcortex
Does not involve:
- Cortex
- Motor neuron
Mechanism of partial seizure
- Cortex occupying lesion like Neurocysticercosis, tumour, gliosis
- Firing of neurons downstairs via Na channels
- Specific neuron: action potential
- Specific segment of spinal cord
- Specific muscle
Anti-epileptic drugs
1. Ca2+ channel 🅱️: Valproate, ethosuximide 2. Na+ channel 🅱️: Phenytoin, carbamazepine, rufinamide, Lacosamide, Topiramate 3. Both of the above: Lamotrigine, zonisamide 4. K+ channel opener: Ezogabine, topiramate 5. Glutamate 🅱️: Felbamate, perampanel,… 6. GABA 🔼: BZD,… Pregabalin, Gabapentin,…
Treatment of generalised seizure
Both Ca and Na channel blockers can be used
DoC: valproate
Myoclonic seizure is worsened by 2 Na channel blockers: carbamazepine and phenytoin
Treatment of partial seizure and absence seizures
DoC for partial seizure: Carbamazepine- Na channel blocker
DoC for absence seizures: valproate
Add on anti epileptics
- K+ channel opener
- Decreasing glutamate effect
- Increasing GABA effect
Duration of treatment of anti epileptics
Upto minimum 2 years of seizure free period except:
1. JME
2. Post infarction seizure
where it is life long therapy
Mechanism of anti epileptic action of valproate
- Calcium channel blocker
- Sodium channel blocker
- Increases GABA by stimulating synthesis and inhibiting metabolism
- Inhibits histone deacetylase
Uses of valproate
DoC in: 1. GTCS 2. Myoclonic seizures 3. Absence seizures 4. Lennox Gastaut syndrome: Also DoC in: 5. Rapid cyclers 6. Rheumatic chorea Treatment of: 7. Acute mania 8. Prophylaxis of migraine
Lennox Gastaut syndrome
Mixed seizure syndrome
Seen usually in children
Refractory seizure- difficult to treat
DoC: valproate
Side effects of valproate
- Nausea, vomiting: M/C
- Alopecia
- Obesity
- Polycystic ovarian disease
- Hepatotoxicity
- Pancreatitis
- Hyperammonemia
- Tremor
- Enzyme inhibitor
Why valproate is not used as 1st line management
S/E like:
- Alopecia
- Obesity
- Polycystic ovarian disease
Hepatotoxicity of valproate
Valproate in hepatotoxic especially in presence of enzyme inducers like phenytoin, carbamazepine
So C/I in:
1. Children < 2 years
2. In pregnancy: neural tube defect, cardiovascular disease
Treatment of epilepsy (JME) during pregnancy on valproate
- Continue valproate (do not stop or change anti epileptics)
- TDM of valproate
- Folic acid:
• normal pregnancy: 400 μg/day
• h/o neural tube defect in previous pregnancy: 4000 μg/day
Treatment of epilepsy (JME) on females on valproate planning pregnancy
Drug free interval: 1. Seizures absent Proceed with planned pregnancy 2. Seizures present: DoC: Levetiracetam Lamotrigine Clonazepam
Ethosuximide
Calcium channel blocker DoC: Absence seizures in children <2 years S/E: 1. Nausea, vomiting - M/C 2. Neurotoxicity 3. Bone marrow suppression 4. SLE
Phenytoin or diphenyl hydantoin
Uses
- GTCS
- Partial seizures
- Treatment of neuropathic pain
- Antiarrhythmic drug
- Given as slow IV as fosphenytoin for treatment of status epilepticus
Fast IV causes asystole
Pharmacokinetics of phenytoin
- The only anti epileptic to follow zero order kinetics ➡️ increased risk of toxicity in case of overdose
- Increased plasma protein binding capacity
Side effects of phenytoin
H. Hyperplasia of gums Hirsutism with acne Y. lYmphadenopathy D. abnormal vit D metabolism ➡️ hypocalcemia Diplopia A. Ataxia Anaemia N. Nystagmus T. Teratogenic O. Osteomalacia I. Induces vit K metabolism N. Neutropenia
Lymphadenopathy of phenytoin
It resembles Hodgkins disease
TDM is advised for phenytoin and carbamazepine when
Diplopia and ataxia are seen as side effects
Fetal hydantoin syndrome
Teratogenic effect of phenytoin
Facial clefts
Vitamin K and phenytoin
Phenytoin induces vitamin K metabolism decreasing vitamin K, effects:
1. Pregnancy
Hemorrhagic disease is newborn
To prevent vitamin K supplements (10 mg/day) in 3rd trimester
2. Decreased bone matrix synthesis
Carbamazepine
Recent derivatives
- Oxcarbazepine: prodrug of eslicarbazepine
- Eslicarbazepine
Both are:
Less toxic so less hypersensitivity
Less enzyme inducers
Uses: GTCS, partial seizure
Uses of carbamazepine
- GTCS
- DoC in partial seizures
- DoC in trigeminal neuralgia
- Bipolar disorder
- Acute mania
Side effects of carbamazepine
H. Hyponatremia SIADH Hypersensitivity E. Eosinophilia A. Agranulocytosis, Aplastic anaemia, Ataxia D. Diplopia and blurring of vision S. Splenomegaly Stevens Johnson syndrome
Hyponatremia as side effect of carbamazepine
More with oxcarbamazepine
Delayed side effects
More common in elderly
SJS Stevens Johnson syndrome
It is seen with both phenytoin and carbamazepine
Associated with:
1. HLA B-1502 gene - Abacavir induced SJS
2. HLA B 5701 gene - allopurinol induced SJS
3. HLA B 5801 gene
Lamotrigine
Mechanism
Wide spectrum:
- Na+ channel blocker
- Ca2+ channel blocker (2nd line treatment in absence seizure)
- Decreased glutamate
Uses of lamotrigine
- 1st line in GTCS, JME and partial seizure, safer drug in pregnancy
- 2nd line in Lennox Gastaut syndrome
- Bipolar disorder during depressive phase
Side effects of lamotrigine
- Nausea, vomiting
- Ataxia/ diplopia
- SJS
Prevented by gradually increasing the dose - sensitisation
So, lamotrigine cannot be given in emergency
Topiramate
Mechanism
Wide spectrum:
- Na channel blocker
- K channel opener
- CA inhibitor
- GABA A agonist
- Blocks glutamate receptor of AMP-A and Kainate subtype
Uses of topiramate
1. GTCS 2 JME 3. Partial seizures 4. LGS 5. Bipolar disorder 6. Prophylaxis of migraine not responding to propranolol 7. Codependence of alcohol, smoking
Side effects of topiramate
- CA inhibition:
• Metabolic acidosis
• Nephrolithiasis
• Hypohidrosis
Used as 2nd line in treatment of pseudotumour cerebri - Weight loss:
Used along with phentermine in treatment of obesity - 2° closed angle glaucoma:
Ophthalmic examination before prescribing
Zonisamide
• Blocks: Na channel Ca channel • Free radical scavenger Uses - partial seizure S/E: CA inhibitor 1. Metabolic acidosis 2. Nephrolithiasis 3. Hypohidrosis
Rufinamide
Blocks Na channel Metabolised by non-microsomal enzymes ➡️ no drug interactions Uses: LGS S/E: 1. QT interval shortening 2. Leukopenia
Lacosamide
Blocks Na channel
Only anti epileptic to cause slow inactivation of Na channels
Sources: amino acid L serine
Uses: partial seizure
S/E:
1. Prolonged PR interval
2. Suicidal tendency (FDA- black box warning)
Potassium channel opener as anti epileptics
Ezogabine/Retigabine 2nd line drug for partial seizure S/E: 1. Pigmentation of skin, lips, nails 2. Tremors 3. Retinal deposits- so ophthalmological examination every 6 months
Drugs that decrease the effects of glutamate used as antiepileptic
1. NMDA receptor blocker: Felbamate Use: GTCS, partial seizure 2. AMPA antagonists: Perampanel Talampanel Use: Partial seizure
Felbamate
NMDA receptor blocker Decrease the effect of glutamate Uses (not preferred): 1. GTCS 2. Partial seizures S/E: 1. Bone marrow suppression 2. Hepatotoxic
Perampanel, Talampanel
AMPA antagonists Decrease effects of glutamate Use - partial seizure S/E: 1. Somnolence 2. Mood abnormality
GABA receptors
Post synaptic 1. GABA-A: Brain Cl- channel Antiepileptic 2. GABA-B: Spinal cord Gi subtype ➡️ K+ channel opener Muscle relaxation
Antiepileptic effect of GABA increasing drugs
1. Direct antiepileptic effect- GABA-A agonist: • Benzodiazepines • Barbiturates • Ganaxolone • Stiripentol 2. Indirect antiepileptic effect: • stimulating pre synaptic GABA release • inhibiting its reuptake • inhibiting its metabolism
Baclofen
GABA-B agonist
Mechanism: muscle relaxation
Use: Amylotrophic lateral sclerosis
Indirect antiepileptic drugs by increasing GABA
- Stimulating release:
Pregabalin, Gabapentin - Inhibits reuptake: Tiagabine
- Inhibits metabolism: Vigabatrin (GABA TRansaminase INhibitor)
Gabapentin and Pregabalin
Mechanism and pharmacokinetics
Mechanism: 1. Binds to presynaptic Ca channel 2. Blocks Ca endocytosis 3. Increases GABA release Pharmacokinetics: Not metabolised ➡️ no drug interactions Excreted unchanged by kidneys
Common uses and side effects of Gabapentin and Pregabalin
Uses: 1. Partial seizure 2. Peripheral neuropathy S/E: 1. Weight gain 2. Oedema
Specific uses of Gabapentin
- Prophylaxis of migraine
- Bipolar disorder
- Generalised anxiety disorder
- Phobia
- Post herpetic neuralgia
Tiagabine
Inhibits GABA reuptake Use: partial seizure S/E: 1. Paradoxical seizure in non-epileptics 2. Psychosis
Vigabatrin
Inhibits GABA transaminase Uses: 1. Resistant partial seizure 2. Infantile spasm: • associated with tuberous sclerosis DoC: Vigabatrin • not associated with tuberous sclerosis DoC: ACTH/ steroids S/E: irreversible visual field defects
Ganaxolone
GABA-A receptor agonist
Uses:
1. Partial seizure
2. Infantile spasm
Stiripentol
Mechanism: 1. GABA-A agonist 2. Increases GABA in synapse Uses: Dravet syndrome (DoC valproate) as an add on drug to valproate or clobazam S/E: anorexia ➡️ weight loss
Synaptic vesicular protein inhibitor
Hypothesis: contraction of SV2A ➡️ excitatory NT
So, SV2A inhibitor 🅱️s excitatory NT (glutamate)
Drugs:
1. Levetiracetam
2. Brivaracetam
Levetiracetam
Mechanism: 1. SV2A inhibitor 2. N type Ca channel blocker M/C in 🤰 for epilepsy: 1. Monotherapy- Levetiracetam DoC 2. Polytherapy: Levetiracetam Lamotrigine Clonazepam
Uses and side effects of Levetiracetam
Uses: 1. GTCS 2. JME 3. Partial seizure 4. Status epilepticus 5. Levodopa induced dyskinesia Safer in pregnancy S/E: 1. Bone marrow suppression 2. Mood abnormalities
Brivaracetam
Mechanism:
1. SV2A inhibitor
2. Na channel blocker
Uses: partial seizure
Cannabidiol
Derivative of cannabis Use: 1. Dravet syndrome 2. Lennox Gastaut syndrome S/E: hepatotoxic Monitor AST/ALT CI: children <2 years